22nd Century Group (XXII) Supports FDA Policy Advancements, Proposed Menthol Ban Now at OMB
October 26, 2023 08:30 ET
|
22nd Century Group, Inc
BUFFALO, N.Y., Oct. 26, 2023 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a leading biotechnology company focused on utilizing advanced plant technologies to improve health and...
22nd Century Group (XXII) Announces Fully Integrated, Single-Source Strategic License, Manufacturing and Distribution Agreement with Cookies
April 05, 2023 08:30 ET
|
22nd Century Group, Inc
Launches Turn-Key Contract Development and Manufacturing Plus Distribution (CDMO+D) Solution for Industry Leading Hemp/Cannabis Brands Highly Accretive Transformative Deal Utilizes Entire 22nd...
22nd Century Group’s GVB Biopharma Opens New Central Distribution Facility in The Netherlands
November 16, 2022 09:25 ET
|
22nd Century Group, Inc
BUFFALO, N.Y., Nov. 16, 2022 (GLOBE NEWSWIRE) -- GVB Biopharma, a 22nd Century Group company (Nasdaq: XXII), today announced that it has opened a new, strategically-located distribution facility in...
22nd Century Group (Nasdaq: XXII) GVB Biopharma to Exhibit at MJBizCon in Las Vegas
November 15, 2022 09:25 ET
|
22nd Century Group, Inc
BUFFALO, N.Y., Nov. 15, 2022 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology company dedicated to improving health with reduced nicotine tobacco,...
22nd Century Group (Nasdaq: XXII) to Participate in November 2022 Investor Conferences
November 14, 2022 08:19 ET
|
22nd Century Group, Inc
BUFFALO, N.Y., Nov. 14, 2022 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology company dedicated to improving health with reduced nicotine tobacco,...
22nd Century Group (Nasdaq: XXII) Reports Business Highlights and Financial Results for the Third Quarter 2022
November 08, 2022 06:00 ET
|
22nd Century Group, Inc
Accelerating VLN® Sales in Colorado and Illinois, Launching in Four Corners States to Capture Market Share and VolumeGVB Biopharma Acquisition Growing Revenue on Increased VolumesThird Quarter Net...
22nd Century Group (Nasdaq: XXII) to Expand VLN® Sales in Three Additional States: Arizona, Utah and New Mexico
October 26, 2022 09:25 ET
|
22nd Century Group, Inc
Combined with Ongoing Launch in Colorado, VLN® Will Be Available in All “Four Corners” StatesUtah and New Mexico Join Colorado as VLN® States with Favorable MRTP Excise Tax Programs BUFFALO, N.Y.,...
22nd Century Group (Nasdaq: XXII) to Present at LD Micro Conference on October 26
October 18, 2022 09:20 ET
|
22nd Century Group, Inc
BUFFALO, N.Y., Oct. 18, 2022 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology company dedicated to improving health with reduced nicotine tobacco,...
22nd Century Group (Nasdaq: XXII) to Participate in the Dawson James Small Cap Growth Conference on October 12
October 06, 2022 16:05 ET
|
22nd Century Group, Inc
BUFFALO, N.Y., Oct. 06, 2022 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology company dedicated to improving health with reduced nicotine tobacco,...
First Cigarette Authorized by FDA to “Help You Smoke Less” Now Available Across Colorado
October 06, 2022 09:30 ET
|
22nd Century Group, Inc
VLN® cigarettes from 22nd Century Group contain 95% less nicotine than conventional cigarettes, greatly reducing nicotine consumption to help smokers smoke less; support State and FDA goals of...